China Medical Imaging Market (By Modality: X-ray, Ultrasound, Computed Tomography, Magnetic Resonance Imaging, Nuclear Medicine; By End-use: Hospitals, Diagnostic Imaging Centers) - Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook and Forecast 2023-2032

The China medical imaging market was valued at USD 1.66 billion in 2022 and it is predicted to surpass around USD 3.04 billion by 2032 with a CAGR of 6.25% from 2023 to 2032.

China Medical Imaging Market Size 2023 to 2032

Key Pointers

  • Ultrasound dominated the product segment with 30% of the China medical imaging market share in 2022. 
  • The computed tomography (CT) scanners segment is expected to grow at the fastest CAGR of 8.34% during the forecast period.  
  • The hospitals segment held the largest revenue share of around 40% in 2022. 
  • The diagnostic imaging centers segment is expected to witness the fastest CAGR of 6.18% over the forecast period.

Report Scope of the China Medical Imaging Market

Report Coverage Details
Market Size in 2022 USD 1.66 billion
Revenue Forecast by 2032 USD 3.04 billion
Growth rate from 2023 to 2032 CAGR of 6.25%
Base Year 2022
Forecast Period 2023 to 2032
Market Analysis (Terms Used) Value (US$ Million/Billion) or (Volume/Units)
Companies Covered GE HealthCare; Siemens Healthcare GmbH; Koninklijke Philips N.V.; Canon Medical Systems Corporation; Shenzhen Mindray Bio-Medical Electronics Co., Ltd.; Shanghai United Imaging Healthcare Co., Ltd

 

Key growth drivers for the market include an increasing demand for early detection & prevention of chronic diseases, as well as a growing geriatric population. Technological advancements in medical imaging further contribute to the utilization of advanced techniques to meet healthcare needs. For instance, in June 2023, GE HealthCare announced the FDA approval and launch of Sonic DL, a deep learning-based technology specifically designed to significantly accelerate MRI image acquisition.

The growing prevalence of chronic diseases plays a significant role in driving the demand for medical imaging devices in China. As chronic diseases such as diabetes, cancer, and cardiovascular conditions become more common, the need for accurate and timely diagnosis increases. Medical imaging devices, such as X-ray, MRI, and CT scans, provide valuable insights into the progression and severity of these chronic diseases. They aid healthcare professionals in detecting and monitoring disease markers, guiding treatment decisions, and evaluating treatment effectiveness. By enabling early detection, precise diagnosis, and effective disease management, medical imaging devices contribute to improved patient outcomes and better quality of life for individuals living with chronic diseases.

Government initiatives play a crucial role in promoting the use of medical imaging devices. By implementing policies and programs that prioritize healthcare infrastructure development, governments encourage the adoption and accessibility of advanced imaging technologies. Funding support, tax incentives, and reimbursement schemes encourage healthcare facilities to invest in medical imaging devices, leading to the improvement and establishment of imaging centers. These initiatives have a positive impact on patient care by increasing access to accurate and timely diagnoses, improving outcomes, and enhancing overall healthcare services for the population. For instance, the government of China has approved the Healthy China 2030 plan, which prioritizes health and aims to participate in global health governance. This initiative is also favorable to market growth.

Technological advancements are essential in driving the use of medical imaging devices. Continuous advancements in imaging technologies, such as better image quality and faster scans, help doctors diagnose patients more accurately. Advanced imaging methods, such as MRI, CT scans, and PET scans, provide detailed and precise information about the body's structures and any abnormalities present. This allows healthcare professionals to make better treatment plans and monitor progress effectively. Furthermore, advancements such as artificial intelligence (AI) and machine learning (ML) help automate processes and analyze images more efficiently. For instance, Koninklijke Philips N.V. launched Philips CT 3500 computed tomography scanner in May 2023 to expand the market by offering state-of-the-art solutions for routine radiology and high-volume screening programs.

Modality Insights

Ultrasound dominated the product segment with 30% of the China medical imaging market share in 2022. This segment is subdivided into 2D, 3D/4D, and Doppler. The 3D/4D segment held the largest revenue share of 38.9% in 2022. Ultrasound with 3D and 4D imaging is used in pregnancy to see a real-time picture of the baby's features and movements. Ultrasound is majorly used in gynecology for the screening and diagnosing of female reproductive organs and diseases such as endometriosis, pelvic inflammatory disease, and reproductive organ cancer.

The increasing demand for ultrasound imaging is driven by several factors. Ultrasound is a safe and non-invasive imaging technique that does not involve radiation exposure, making it preferred for pregnant women and children. It is also widely available and more affordable compared to other imaging methods, making it accessible to more people. Advancements in ultrasound technology have improved image quality, allowing better visualization of internal structures and accurate diagnosis of medical conditions.

Ultrasound is versatile and can be used to assess various body parts and systems, including the abdomen, heart, and blood vessels. With the rising prevalence of chronic diseases, there is a growing need for regular monitoring and early detection, driving the demand for ultrasound as a reliable and effective imaging tool. Its benefits in terms of safety, accessibility, versatility, and accuracy contribute to the increasing demand for ultrasound imaging.

The computed tomography (CT) scanners segment is expected to grow at the fastest CAGR of 8.34% during the forecast period. Technological advancements in CT technology, coupled with the growing prevalence of chronic disorders such as cancer, orthopedics, and cardiovascular and neurological conditions are expected to accelerate the market growth over the forecast period.

End-use Insights

Based on end-use, the China medical imaging market has been segmented into hospitals, diagnostic imaging centers, and others. The hospitals segment held the largest revenue share of around 40% in 2022. The growing demand for more accurate diagnostic tools, advancements in imaging technology, expanding healthcare infrastructure, increased awareness about the benefits of early disease detection, and the rising prevalence of chronic diseases. These factors collectively contribute to the rising utilization of medical imaging devices across various medical specialties and healthcare settings.

The diagnostic imaging centers segment is expected to witness the fastest CAGR of 6.18% over the forecast period. The increasing demand for timely and accurate diagnoses has led to a rise in the number of imaging tests performed at dedicated centers, diagnostic imaging centers often have access to advanced imaging technologies and specialized expertise, attracting patients seeking comprehensive diagnostic services. Additionally, advancements in imaging technology have made it more convenient and cost-effective for healthcare providers to outsource imaging services to these centers, further driving their growth.

China Medical Imaging Market Segmentations:

By Modality 

  • X-ray
    • Radiography
    • Fluoroscopy
    • Mammography
  • Ultrasound
    • 2D
    • 3D/4D
    • Doppler
  • Computed Tomography (CT)
    • High slice
    • Mid slice
    • Low slice
    • Cone beam
  • Magnetic Resonance Imaging (MRI)
    • Low - strength
    • Mid - strength
    • High - strength
  • Nuclear Medicine
    • SPECT
    • PET

By End-use 

  • Hospitals
  • Diagnostic Imaging Centers
  • Others

Frequently Asked Questions

The China medical imaging market size was reached at USD 1.66 billion in 2022 and it is projected to hit around USD 3.04 billion by 2032.

The China medical imaging market is growing at a compound annual growth rate (CAGR) of 6.25% from 2023 to 2032.

Key factors that are driving the China medical imaging market growth include rising need for solutions to reduce healthcare costs, increasing focus on patient-centric care, and strong government support.

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis 

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on China Medical Imaging Market 

5.1. COVID-19 Landscape: China Medical Imaging Industry Impact

5.2. COVID 19 - Impact Assessment for the Industry

5.3. COVID 19 Impact: Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. China Medical Imaging Market, By Modality

8.1. China Medical Imaging Market, by Modality, 2023-2032

8.1.1. X-ray

8.1.1.1. Market Revenue and Forecast (2020-2032)

8.1.2. Ultrasound

8.1.2.1. Market Revenue and Forecast (2020-2032)

8.1.3. Computed Tomography (CT)

8.1.3.1. Market Revenue and Forecast (2020-2032)

8.1.4. Magnetic Resonance Imaging (MRI)

8.1.4.1. Market Revenue and Forecast (2020-2032)

8.1.5. Nuclear Medicine

8.1.5.1. Market Revenue and Forecast (2020-2032)

Chapter 9. China Medical Imaging Market, By End-use

9.1. China Medical Imaging Market, by End-use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Forecast (2020-2032)

9.1.2. Diagnostic Imaging Centers

9.1.2.1. Market Revenue and Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Forecast (2020-2032)

Chapter 10. China Medical Imaging Market, Regional Estimates and Trend Forecast

10.1. China

10.1.1. Market Revenue and Forecast, by Modality (2020-2032)

10.1.2. Market Revenue and Forecast, by End-use (2020-2032)

Chapter 11. Company Profiles

11.1. GE HealthCare

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Siemens Healthcare GmbH

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Koninklijke Philips N.V.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Canon Medical Systems Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. LTE Scientific

11.5. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. Shanghai United Imaging Healthcare Co., Ltd

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Proceed To Buy

USD 3800
USD 1900
USD 1200

Customization Offered

  • check-imgCross-segment Market Size and Analysis for Mentioned Segments
  • check-imgAdditional Company Profiles (Upto 5 With No Cost)
  • check-img Additional Countries (Apart From Mentioned Countries)
  • check-img Country/Region-specific Report
  • check-img Go To Market Strategy
  • check-imgRegion Specific Market Dynamics
  • check-imgRegion Level Market Share
  • check-img Import Export Analysis
  • check-imgProduction Analysis
  • check-imgOthers